China's IVD Market: An Opportunity For Surplus Revenue Growth

China's IVD Market: An Opportunity For Surplus Revenue Growth

China represents the most attractive IVD market in the developing world and among developing nations. Additionally, the Chinese IVD market has been and is projected to be the fastest growing among the top-ten national IVD markets. This article describes the opportunity in China and the reasons it's market continues to show better-than-world-average growth.


Chinese Market Comes to the Fore in Cancer Diagnostics

Chinese Market Comes to the Fore in Cancer Diagnostics

In 2016, China is a clear market development priority for the IVD industry in the areas of cancer screening tests, companion diagnostics, and sequencing-based cancer assays.


Blood Screening Leads Revival of China’s National Blood Program

Blood Screening Leads Revival of China’s National Blood Program

Investment in screening diagnostics is pivotal in China’s effort to strengthen its scandal-bitten national blood program. Kalorama Information’s recently published Blood Testing Market in China provides IVD-relevant insights into both regional and national demand for blood screening products in China. Blood supply in China is insufficient today to meeting clinical demand in China, but increased donation is being encouraged as blood centers update screening standards and works to improve transfus...


Propelled by NIPT, China Moves to the Fore in NGS Assays

Propelled by NIPT, China Moves to the Fore in NGS Assays

China is playing an increasingly significant role not only in the IVD industry, but global clinical markets. Kalorama Information offers comprehensive subject reports that variously treat the Chinese IVD , global cancer diagnostics , prenatal testing , circulating tumor cells (CTCs) , and next-generation sequencing (NGS) markets.

The stakes are high for clinical next-generation sequencing (NGS) platform vendors in the Chinese market. In 2014, the Chinese Food & Drug Administration (CFDA; SFDA)...

  • by bcarlson@marketresearch.com
  • April 21 2014
  • China


Nearly 40 million Surgeries Performed in China Last Year

Nearly 40 million Surgeries Performed in China Last Year

Our newly -released Surgical Procedure Volumes: Global Analysis report informs us that the total number of surgical procedures in China is estimated at 39.5 million for 2013. This is nearly one sixth of the world’s surgical operations. The majority of procedures are in the area of obstetrical and gynecological procedures, followed by digestive and gastrointestinal system procedures.

China boasts 1.3 billion people and this is expected to grow to 1.4 by 2020. The growth of the Chinese economy, ...


Hematology Industry Mapping and Its Boundaries

Hematology Industry Mapping and Its Boundaries

Laboratory hematology is largely synonymous with its leading vendors such as Beckman Coulter and Sysmex. High order volumes among such vendors are ensured through established relationships with premium clients such as care networks, other large healthcare institutions, clinical laboratories, and reference labs. The profile of companies such as Beckman Coulter and Abbott Diagnostics is also higher due to the breadth of their product offering, particularly within the core lab - clinical chemistry,...